Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
4
×
clinical trials
4
×
inclisiran
4
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
regeneron pharmaceuticals
new york
the medicines co.
alnylam pharmaceuticals
biotech
cholesterol
fda
novartis
pcsk9
pcsk9 inhibitors
praluent
repatha
san francisco blog main
san francisco top stories
sanofi
3b pharmaceuticals
abeona therapeutics
acute myeloid leukemia
adicet bio
aegerion pharmaceuticals
akcea therapeutics
alirocumab
alkermes
allan kaspar
altria
amphivena therapeutics
amryt pharma
andrew komjathy
aron knickerbocker
artara therapeutics
What
cholesterol
drug
medco
medicines
fda
lowering
twice
according
aces
acquire
agreed
akcea
announced
big
billion
biotech
bringing
brings
cases
cash
centers
ceo
cigarettes
clears
closer
company
compound
control
deal
deaths
disease
electronic
filing
flexible
inched
inclisiran
including
injuries
key
linked
Language
unset
Current search:
inclisiran
×
" boston top stories "
×
" clinical trials "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing